{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:10:06Z","timestamp":1787505006509,"version":"build-2736575974"},"reference-count":68,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD08\/0075"],"award-info":[{"award-number":["RD08\/0075"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD12\/0009\/0013"],"award-info":[{"award-number":["RD12\/0009\/0013"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD16\/0012"],"award-info":[{"award-number":["RD16\/0012"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.semarthrit.2020.03.023","type":"journal-article","created":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T11:15:37Z","timestamp":1589541337000},"page":"608-615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Biologic therapy in severe and refractory peripheral ulcerative keratitis (PUK). Multicenter study of 34 patients"],"prefix":"10.1016","volume":"50","author":[{"given":"Lucia C.","family":"Dominguez-Casas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"S\u00e1nchez-Bilbao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanesa","family":"Calvo-R\u00edo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Ma\u00edz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Beltr\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Mart\u00ednez-Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosal\u00eda","family":"Demetr\u00edo-Pablo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda \u00c1lvarez","family":"del Buergo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Rubio-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"D\u00edaz-Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Lopez-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel M.","family":"Garc\u00eda-Aparicio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio J.","family":"Mas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Vegas-Revenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santos","family":"Casta\u00f1eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L.","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Gonz\u00e1lez-Gay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2020.03.023_bib0001","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.rdc.2007.08.002","article-title":"Scleritis and peripheral ulcerative keratitis","volume":"33","author":"Galor","year":"2007","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0002","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2147\/OPTH.S24947","article-title":"Update on peripheral ulcerative keratitis","volume":"6","author":"Yagci","year":"2012","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0003","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/1756-185X.12688","article-title":"Ulcerative keratitis patients with rheumatoid arthritis in the modern biologic era: a series of eight cases and literature review","volume":"20","author":"Watanabe","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0004","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrrheum.2013.185","article-title":"Ocular inflammatory diseases associated with rheumatoid arthritis","volume":"10","author":"Artifoni","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0005","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0161-6420(03)00721-8","article-title":"Tumor necrosis factor a blockade with infliximab for refractory uveitis and scleritis","volume":"111","author":"Murphy","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0006","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s12348-012-0080-z","article-title":"Adalimumab for refractory peripheral ulcerative keratitis","volume":"2","author":"Cordero-Coma","year":"2012","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0007","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/ICO.0b013e318181a84f","article-title":"Infliximab for the treatment of refractory progressive sterile peripheral ulcerative keratitis associated with late corneal perforation: 3-year follow-up","volume":"28","author":"Odorcic","year":"2009","journal-title":"Cornea"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0008","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/ICO.0b013e3181c296ed","article-title":"Rituximab for peripheral ulcerative keratitis with wegener granulomatosis","volume":"29","author":"Huerva","year":"2010","journal-title":"Cornea"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0009","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/01.ico.0000154391.28254.1d","article-title":"Therapy of progressive rheumatoid arthritis associated corneal ulceration with infliximab","volume":"24","author":"Thomas","year":"2005","journal-title":"Cornea"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0010","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.oftal.2011.01.003","article-title":"Rituximab en queratitis ulcerativa perif\u00e9rica asociada a artritis reumatoide","volume":"86","author":"Albert","year":"2011","journal-title":"Arch Soc Esp Oftalmol"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0011","series-title":"Smolin and thoft's: the cornea, scientific foundations and clinical practice","article-title":"Mooren's ulcer","author":"Foster","year":"2005"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0012","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"Rheumatoid arthritis classification criteria. An American College of Rheumatology\/European League against Rheumatism Collaborative Initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0013","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0014","doi-asserted-by":"crossref","unstructured":"International Study Group for Behcet's Disease. Criteria for diagnosis of Behcet's disease. Lancet 1990 (8697);335:1078\u201380.","DOI":"10.1016\/0140-6736(90)92643-V"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0015","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/art.1780330805","article-title":"The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa","volume":"33","author":"Lightfoot","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0016","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0017","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","article-title":"The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis","volume":"33","author":"Leavitt","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0018","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.2010.133645","article-title":"The Assessment of Spondyloarthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general","volume":"70","author":"Rudwaleit","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"Jun 25","key":"10.1016\/j.semarthrit.2020.03.023_bib0019","article-title":"Comparative study of infliximab versus adalimumab in refractory uveitis due to Beh\u00e7et's disease","author":"Atienza\u2010Mateo","year":"2019","journal-title":"National multicenter study of 177 cases"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0020","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.semarthrit.2015.05.010","article-title":"Anti-TNF-alfa therapy in refractory uveitis associated with sarcoidosis: multicenter study of 17 patients","volume":"45","author":"Riancho-Zarrabeitia","year":"2015","journal-title":"Semin Arthritis Rheum"},{"issue":"Jul-Aug (4","key":"10.1016\/j.semarthrit.2020.03.023_bib0021","first-page":"652","article-title":"Golimumab in refractory uveitis associated to juvenile idiopathic arthritis: multicentre study of 7 cases and literature review","volume":"36","author":"Palmou-Fontana","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0022","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.semarthrit.2016.03.002","article-title":"Golimumab in refractory uveitis related to spondyloarthritis. Multicenter study of 15 patients","volume":"46","author":"Calvo-R\u00edo","year":"2016","journal-title":"Semin Arthritis Rheum"},{"issue":"Sep (9","key":"10.1016\/j.semarthrit.2020.03.023_bib0023","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.ophtha.2018.02.020","article-title":"Successful optimization of adalimumab therapy in refractory uveitis due to Beh\u00e7et's disease","volume":"125","author":"Mart\u00edn-Varillas","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0024","series-title":"In: Kanski's: clinical ophthalmology","first-page":"167","author":"Cornea","year":"2016"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/bjo.60.3.163","article-title":"Scleritis and episcleritis","volume":"60","author":"Watson","year":"1976","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0026","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.semarthrit.2008.08.003","article-title":"Systemic nonarticular manifestations of rheumatoid arthritis: focus on inflammatory mechanisms","volume":"39","author":"Moreland","year":"2009","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0027","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0028","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.berh.2016.10.007","article-title":"The eye and inflammatory rheumatic diseases: the eye and rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis","volume":"30","author":"Murray","year":"2016","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0029","unstructured":"Soukiasian, Sarkis H.Peripheral Ulcerative Keratitis. In: Ophthalmology, 5th ed.. Philadelphia: Elsevier; 2019, p. 240\u201343"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0030","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.1097\/MD.0000000000000176","article-title":"Infliximab for peripheral ulcerative keratitis treatment","volume":"93","author":"Huerva","year":"2014","journal-title":"Medicine"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0031","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/7298026","article-title":"Peripheral ulcerative keratitis associated with autoimmune disease: pathogenesis and treatment","volume":"2017","author":"Cao","year":"2017","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0032","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1136\/bjo.83.8.941","article-title":"Incidence of corneal melting in association with systemic disease in the Yorkshire region","volume":"83","author":"McKibbin","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0033","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrrheum.2013.185","article-title":"Ocular inflammatory diseases associated with rheumatoid arthritis","volume":"10","author":"Artifoni","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0034","series-title":"Cornea","first-page":"1050","article-title":"Corneal disease in rheumatoid arthritis","author":"Shabnam","year":"2017"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0035","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.clae.2013.07.013","article-title":"Peripheral ulcerative keratitis in association with sarcoidosis","volume":"36","author":"Harthan","year":"2013","journal-title":"Cont Lens Anterior Eye"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0036","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/rheumatology\/38.12.1245","article-title":"Peripheral ulcerative keratitis \u2018corneal melt\u2019 and rheumatoid arthritis: a case series","volume":"38","author":"Squirrell","year":"1999","journal-title":"Rheumatology"},{"issue":"7","key":"10.1016\/j.semarthrit.2020.03.023_bib0037","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s41927-019-0108-1","article-title":"Two cases of perforated corneal ulcers complicating rheumatoid arthritis treated successfully by biological therapy","volume":"4","author":"Bench\u00e9rifa","year":"2020","journal-title":"BMC Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0038","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3899\/jrheum.170437","article-title":"Clinical correlates, outcomes, and predictors of inflammatory ocular disease associated with rheumatoid arthritis in the biologic era","volume":"45","author":"Caimmi","year":"2018","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0039","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3899\/jrheum.101133","article-title":"Incidence of extraarticular rheumatoid arthritis in Olmsted County, Minnesota, in 1995-2007 versus 1985-1994: a population-based study","volume":"38","author":"Myasoedova","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0040","first-page":"1","article-title":"Demographic profile, clinical features and outcome of peripheral ulcerative keratitis: a prospective study","volume":"0","author":"Sharma","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0041","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0161-6420(84)34160-4","article-title":"Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis effects of systemic immunosuppression","volume":"91","author":"Foster","year":"1984","journal-title":"Ophtalmology"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0042","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/rheumatology\/kex007","article-title":"Rapid healing of peripheral ulcerative keratitis in rheumatoid arthritis with prednisone, methotrexate and Adalimumab combination therapy","volume":"56","author":"Korsten","year":"2017","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.03.023_bib0043","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.ophtha.2009.03.019","article-title":"Adalimumab for Mooren's ulcer","volume":"16","author":"Cordero-Coma","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0044","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.ICL.0000092064.05514.04","article-title":"Recombinant human tumor necrosis factor receptor Fc fusion protein (Etanercept): experience as a therapy for sight-threatening scleritis and sterile corneal ulceration","volume":"30","author":"Hernandez-Illas","year":"2004","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0045","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2169\/internalmedicine.0215-17","article-title":"Peripheral ulcerative keratitis associated with granulomatosis with polyangiitis emerging despite cyclophosphamide, successfully treated with rituximab","volume":"57","author":"Fujita","year":"2018","journal-title":"Intern Med"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0046","first-page":"3","article-title":"A case of peripheral ulcerative keratitis associated with autoimmune hepatitis","author":"Eshraghi","year":"2017","journal-title":"Case Rep Med"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0047","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1055\/s-0042-121315","article-title":"Necrotising scleritis and peripheral ulcerative keratitis associated with rheumatoid arthritis treated with rituximab","volume":"234","author":"Hardy","year":"2017","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0048","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1097\/ICO.0000000000000919","article-title":"Successful treatment strategies in granulomatosis with polyangiitis-associated peripheral ulcerative keratitis","volume":"35","author":"Ebrahimiadib","year":"2016","journal-title":"Cornea"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0049","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/bjophthalmol-2016-308838","article-title":"Management of severe and refractory Mooren's ulcers with rituximab","volume":"101","author":"Guindolet","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0050","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000336188","article-title":"Rituximab for noninfectious uveitis","volume":"51","author":"Miserocchi","year":"2012","journal-title":"Dev Ophthalmol"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0051","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ad.2011.07.004","article-title":"Follicular lymphoma with paraneoplastic autoimmune multiorgan syndrome","volume":"103","author":"Hidalgo","year":"2012","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0052","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.autrev.2011.07.001","article-title":"Anti-CD 20 monoclonal antibody (rituximab) treatment for inflammatory ocular diseases","volume":"11","author":"Miserocchi","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0053","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/rheumatology\/kep390","article-title":"A case of bilateral peripheral ulcerative keratitis following treatment with rituximab","volume":"49","author":"Goodisson","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0054","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1136\/bjo.2006.113316","article-title":"Rituximab treatment for peripheral ulcerative keratitis associated with Wegener's granulomatosis","volume":"91","author":"Freidlin","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0055","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1002\/art.38398","article-title":"Efficacy of tocilizumab in conventional treatment-refractory adult-onset Still's disease: multicenter retrospective open-label study of thirty-four patients","volume":"66","author":"Ortiz-Sanju\u00e1n","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0056","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.berh.2016.08.003","article-title":"Adult-onset Still's disease: advances in the treatment","volume":"30","author":"Casta\u00f1eda","year":"2016","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0057","first-page":"S44","article-title":"Tocilizumab in patients with Takayasu arteritis: a retrospective study and literature review","volume":"34","author":"Loricera","year":"2016","journal-title":"Clin Exp Rheumatol"},{"issue":"Aug (1","key":"10.1016\/j.semarthrit.2020.03.023_bib0058","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.semarthrit.2019.01.003","article-title":"Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice","volume":"49","author":"Calder\u00f3n-Goercke","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0059","first-page":"S79","article-title":"Tocilizumab in refractory aortitis: study on 16 patients and literature review","volume":"32","author":"Loricera","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0060","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/art.39940","article-title":"Anti-interleukin-6 receptor tocilizumab for severe juvenile idiopathic arthritis-associated uveitis refractory to anti-tumor necrosis factor therapy: a multicenter study of twenty-five patients","volume":"69","author":"Calvo-R\u00edo","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0061","first-page":"1","article-title":"Efficacy of anti-il6-receptor tocilizumab in refractory cystoid macular edema of birdshot retinochoroidopathy report of two cases and literature review","volume":"11","author":"Calvo-R\u00edo","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0062","first-page":"S54","article-title":"Tocilizumab in uveitis refractory to other biologic drugs: a study of 3 cases and a literature review","volume":"32","author":"Calvo-R\u00edo","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0063","first-page":"34","article-title":"The effect of biologic therapy different from infliximab or adalimumab in patients with refractory uveitis due to Beh\u00e7et's disease: results of a multicentre open-label study","volume":"34","author":"Santos-G\u00f3mez","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.03.023_bib0064","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/rheumatology\/kex480","article-title":"Anti-il6-receptor tocilizumab in refractory uveitis associated with Beh\u00e7et's disease. multicenter retrospective study.","volume":"57","author":"Atienza-Mateo","year":"2018","journal-title":"Rheumatology"},{"issue":"Aug (4 Suppl 84","key":"10.1016\/j.semarthrit.2020.03.023_bib0065","first-page":"S54","article-title":"Tocilizumab in uveitis refractory to other biologic drugs: a study of 3 cases and a literature review","volume":"32","author":"Calvo-R\u00edo","year":"2014","journal-title":"Clin Exp Rheumatol"},{"issue":"Apr","key":"10.1016\/j.semarthrit.2020.03.023_bib0066","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ajo.2018.12.019","article-title":"Anti-IL6-receptor tocilizumab in refractory and noninfectious uveitic cystoid macular edema: multicenter study of 25 patients","volume":"200","author":"Vegas-Revenga","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"Aug (1","key":"10.1016\/j.semarthrit.2020.03.023_bib0067","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.semarthrit.2017.12.012","article-title":"Abatacept in patients with rheumatoid arthritis and interstitial lung disease: a national multicentre study of 63 patients","volume":"48","author":"Fern\u00e1ndez-D\u00edaz","year":"2018","journal-title":"Semin Arthritis Rheum"},{"issue":"Dec 4","key":"10.1016\/j.semarthrit.2020.03.023_bib0068","first-page":"53","article-title":"Tofacitinib for refractory uveitis and scleritis","volume":"13","author":"Paley","year":"2018","journal-title":"Am J Ophthalmol Case Rep"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017220300949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017220300949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:02:01Z","timestamp":1758733321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017220300949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0049017220300949"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2020.03.023","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biologic therapy in severe and refractory peripheral ulcerative keratitis (PUK). Multicenter study of 34 patients","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2020.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}